These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4697240)

  • 1. Effects of 5,6-dihydroxytryptamine on nerve terminal serotonin and serotonin uptake in the rat brain.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Apr; 53(1):117-27. PubMed ID: 4697240
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat.
    Baumgarten HG; Evetts KD; Holman RB; Iversen LL; Vogt M; Wilson G
    J Neurochem; 1972 Jun; 19(6):1587-97. PubMed ID: 4402486
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Effects of 5,6-dihydroxytryptamine on the metabolism of 5-hydroxytryptamine in the central nervous system of the rat.
    Baldessarini RJ; Gerson S
    J Pharm Pharmacol; 1973 Aug; 25(8):647-8. PubMed ID: 4148434
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C
    J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A
    Acta Physiol Scand Suppl; 1973; 391():1-19. PubMed ID: 4521070
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5, 6-dihydroxytryptamine induced degeneration.
    Nygren LG; Fuxe K; Jonsson G; Olson L
    Brain Res; 1974 Oct; 78(3):377-94. PubMed ID: 4424711
    [No Abstract]   [Full Text] [Related]  

  • 9. Axonal degeneration and regeneration of bulbo-spinal indolamine neurons after 5,6-dihydroxytryptamine treatment.
    Nobin A; Baumgarten HG; Björklund A; Lachenmayer L; Stenevi U
    Brain Res; 1973 Jun; 56():1-24. PubMed ID: 4715620
    [No Abstract]   [Full Text] [Related]  

  • 10. Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection.
    Fuxe K; Ungerstedt U
    J Pharm Pharmacol; 1967 May; 19(5):335-7. PubMed ID: 4382408
    [No Abstract]   [Full Text] [Related]  

  • 11. Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Feb; 50(1):214-20. PubMed ID: 4690548
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 5-hydroxytryptophan on serotonin in nerve endings.
    McBride WJ; Aprison MH; Hingtgen JN
    J Neurochem; 1974 Aug; 23(2):385-91. PubMed ID: 4547408
    [No Abstract]   [Full Text] [Related]  

  • 13. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT; Alcaraz AF
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-hydroxytryptamine--a new tool in monoamine fluorescence histochemistry.
    Jonsson G; Fuxe K; Hamberger B; Hökfelt T
    Brain Res; 1969 Mar; 13(1):190-5. PubMed ID: 5806139
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibition of 3 H-biogenic amine uptake by 5,6-dihydroxytryptamine: a comparison with the effects of 6-hydroxydopamine.
    Heikkila RE; Cohen G
    Eur J Pharmacol; 1973 Jan; 21(1):66-9. PubMed ID: 4709207
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation and disappearance of 3 H-5-hydroxytryptamine formed in vivo from 3 H-tryptophan in various regions of the rat brain.
    Schubert J; Sedvall G
    Eur J Pharmacol; 1972 Jan; 17(1):75-80. PubMed ID: 5016584
    [No Abstract]   [Full Text] [Related]  

  • 18. Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: correlations with serotonin levels and histochemical fluorescence.
    Kuhar MJ; Aghajanian GK; Roth RH
    Brain Res; 1972 Sep; 44(1):165-76. PubMed ID: 5056975
    [No Abstract]   [Full Text] [Related]  

  • 19. Further mapping of central 5-hydroxytryptamine neurons: studies with the neurotoxic dihydroxytryptamines.
    Fuxe K; Jonsson G
    Adv Biochem Psychopharmacol; 1974; 10():1-12. PubMed ID: 4846539
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat.
    Björklund A; Baumgarten HG; Lachenmayer L; Rosengren E
    Cell Tissue Res; 1975 Aug; 161(2):145-55. PubMed ID: 1175203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.